Bethany Cushing, Benjamin Jacob, XinYi Low, Sam McGlynn, Ildiko Horvath, Martina Vranka, Tytti Sarkeala, Patrick Redmond
{"title":"肺癌筛查的招募策略:一个总括性审查方案。","authors":"Bethany Cushing, Benjamin Jacob, XinYi Low, Sam McGlynn, Ildiko Horvath, Martina Vranka, Tytti Sarkeala, Patrick Redmond","doi":"10.12688/hrbopenres.14160.1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Lung cancer is the leading cause of cancer-related mortality worldwide. Low-dose CT (LDCT) lung cancer screening (LCS) reduces lung cancer-specific mortality by 20%, yet participation remains low, often below 15%, compared with 60-75% for other cancer screening programmes. Barriers such as limited accessibility, stigma, fear of diagnosis, and misconceptions contribute to poor uptake, particularly among high-risk groups, including heavy smokers, ethnic minorities, and individuals from lower socioeconomic backgrounds. Various recruitment strategies-such as personalised invitations, media campaigns, and primary care referrals-have been implemented, but their effectiveness across different populations remains unclear. This umbrella review will synthesise evidence from systematic reviews to identify the most effective recruitment strategies for improving LCS participation.</p><p><strong>Methods: </strong>This umbrella review will follow Joanna Briggs Institute guidelines and the PRIOR reporting framework. A systematic search of PubMed, Embase, Scopus, Web of Science, Cochrane Library, and systematic review registries will identify systematic reviews published before 31 October 2024. Eligible reviews must evaluate LCS recruitment strategies and report on at least one of the following: population reach, screening up take, adherence, patient experience, or implementation barriers. Quality will be assessed using AMSTAR 2, and overlapping primary studies will be mapped to prevent duplication. A narrative synthesis will categorise recruitment strategies, and a qualitative effectiveness ranking will summarise key findings.</p><p><strong>Implications: </strong>Findings will inform LCS recruitment strategies in Europe, contributing to the EU4Health-funded EUCanScreen programme. This review will support efforts to improve uptake, reduce disparities, and enhance early detection and survival outcomes of lung cancer.</p>","PeriodicalId":73254,"journal":{"name":"HRB open research","volume":"8 ","pages":"71"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12375178/pdf/","citationCount":"0","resultStr":"{\"title\":\"Recruitment Strategies for Lung Cancer Screening: An Umbrella Review Protocol.\",\"authors\":\"Bethany Cushing, Benjamin Jacob, XinYi Low, Sam McGlynn, Ildiko Horvath, Martina Vranka, Tytti Sarkeala, Patrick Redmond\",\"doi\":\"10.12688/hrbopenres.14160.1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Lung cancer is the leading cause of cancer-related mortality worldwide. Low-dose CT (LDCT) lung cancer screening (LCS) reduces lung cancer-specific mortality by 20%, yet participation remains low, often below 15%, compared with 60-75% for other cancer screening programmes. Barriers such as limited accessibility, stigma, fear of diagnosis, and misconceptions contribute to poor uptake, particularly among high-risk groups, including heavy smokers, ethnic minorities, and individuals from lower socioeconomic backgrounds. Various recruitment strategies-such as personalised invitations, media campaigns, and primary care referrals-have been implemented, but their effectiveness across different populations remains unclear. This umbrella review will synthesise evidence from systematic reviews to identify the most effective recruitment strategies for improving LCS participation.</p><p><strong>Methods: </strong>This umbrella review will follow Joanna Briggs Institute guidelines and the PRIOR reporting framework. A systematic search of PubMed, Embase, Scopus, Web of Science, Cochrane Library, and systematic review registries will identify systematic reviews published before 31 October 2024. Eligible reviews must evaluate LCS recruitment strategies and report on at least one of the following: population reach, screening up take, adherence, patient experience, or implementation barriers. Quality will be assessed using AMSTAR 2, and overlapping primary studies will be mapped to prevent duplication. A narrative synthesis will categorise recruitment strategies, and a qualitative effectiveness ranking will summarise key findings.</p><p><strong>Implications: </strong>Findings will inform LCS recruitment strategies in Europe, contributing to the EU4Health-funded EUCanScreen programme. This review will support efforts to improve uptake, reduce disparities, and enhance early detection and survival outcomes of lung cancer.</p>\",\"PeriodicalId\":73254,\"journal\":{\"name\":\"HRB open research\",\"volume\":\"8 \",\"pages\":\"71\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-06-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12375178/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"HRB open research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12688/hrbopenres.14160.1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"HRB open research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12688/hrbopenres.14160.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:肺癌是世界范围内癌症相关死亡的主要原因。低剂量CT (LDCT)肺癌筛查可使肺癌特异性死亡率降低20%,但参与率仍然很低,通常低于15%,而其他癌症筛查规划的参与率为60-75%。可及性有限、污名化、害怕诊断和误解等障碍导致吸收不良,特别是在高危人群中,包括重度吸烟者、少数民族和社会经济背景较低的个人。各种招聘策略——如个性化邀请、媒体宣传和初级保健转诊——已经实施,但它们在不同人群中的有效性尚不清楚。这项总括性审查将综合来自系统审查的证据,以确定最有效的招聘策略,以改善LCS的参与。方法:本综述将遵循乔安娜布里格斯研究所的指导方针和PRIOR报告框架。对PubMed、Embase、Scopus、Web of Science、Cochrane Library和系统综述注册表进行系统搜索,将识别2024年10月31日之前发表的系统综述。符合条件的综述必须评估LCS招募策略,并报告以下至少一项:人群覆盖范围、筛查、依从性、患者体验或实施障碍。将使用AMSTAR 2评估质量,并绘制重叠的初步研究图以防止重复。叙述性综合将对招聘策略进行分类,定性有效性排名将总结主要发现。启示:研究结果将为欧洲LCS招聘策略提供信息,为欧盟卫生资助的eucansscreen项目做出贡献。这篇综述将支持改善摄取、减少差异、提高肺癌的早期发现和生存结果的努力。
Recruitment Strategies for Lung Cancer Screening: An Umbrella Review Protocol.
Background: Lung cancer is the leading cause of cancer-related mortality worldwide. Low-dose CT (LDCT) lung cancer screening (LCS) reduces lung cancer-specific mortality by 20%, yet participation remains low, often below 15%, compared with 60-75% for other cancer screening programmes. Barriers such as limited accessibility, stigma, fear of diagnosis, and misconceptions contribute to poor uptake, particularly among high-risk groups, including heavy smokers, ethnic minorities, and individuals from lower socioeconomic backgrounds. Various recruitment strategies-such as personalised invitations, media campaigns, and primary care referrals-have been implemented, but their effectiveness across different populations remains unclear. This umbrella review will synthesise evidence from systematic reviews to identify the most effective recruitment strategies for improving LCS participation.
Methods: This umbrella review will follow Joanna Briggs Institute guidelines and the PRIOR reporting framework. A systematic search of PubMed, Embase, Scopus, Web of Science, Cochrane Library, and systematic review registries will identify systematic reviews published before 31 October 2024. Eligible reviews must evaluate LCS recruitment strategies and report on at least one of the following: population reach, screening up take, adherence, patient experience, or implementation barriers. Quality will be assessed using AMSTAR 2, and overlapping primary studies will be mapped to prevent duplication. A narrative synthesis will categorise recruitment strategies, and a qualitative effectiveness ranking will summarise key findings.
Implications: Findings will inform LCS recruitment strategies in Europe, contributing to the EU4Health-funded EUCanScreen programme. This review will support efforts to improve uptake, reduce disparities, and enhance early detection and survival outcomes of lung cancer.